# Immunologic Monitoring (IM)

> **NIH NIH P30** · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2021 · $120,212

## Abstract

PROJECT SUMMARY/ABSTRACT (IMMUNE MONITORING)
The Immune Monitoring (IM) Shared Resource (SR) was established by the University of Michigan
Comprehensive Cancer Center (UMCCC) in 1999 and has been continuously funded by the CCSG since 2001.
The goal of this SR is to foster, facilitate, and support basic, translational and clinical researchers who seek to
enhance understanding of cancer immune response and therapy. The IM SR benefits from the leadership of
Co-Directors who are internationally recognized immunologists. Together, they provide leading-edge scientific
knowledge and front-line researcher perspectives as they guide SR services, equipment, and technology.
Users pursue basic science and translational research, with the goal of advancing knowledge of the role of the
immune and inflammatory responses in cancer initiation, progression and metastasis, as well as therapeutic
efficacy and resistance.

## Key facts

- **NIH application ID:** 10198783
- **Project number:** 5P30CA046592-32
- **Recipient organization:** UNIVERSITY OF MICHIGAN AT ANN ARBOR
- **Principal Investigator:** WEIPING ZOU
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $120,212
- **Award type:** 5
- **Project period:** 1997-06-01 → 2023-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10198783

## Citation

> US National Institutes of Health, RePORTER application 10198783, Immunologic Monitoring (IM) (5P30CA046592-32). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10198783. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*